To: Sigmund who wrote (981 ) 1/7/1998 3:54:00 PM From: Frank Buck Read Replies (1) | Respond to of 1894
Sigmund and Others, I have taken Dana's suggestion to review some objective (non-Company issued) information. Here is a link that goes right to the experts in the field.blackwell-science.com The link is marked to an abstract of a text that has been published from an "amalgamation of published papers on HPV". The condensing of these papers (published by internationally-regarded experts) into a book format makes it a very comprehensive read. Not to mention a "one-stop-shop". Some section titles that I thought were of interest (for-our-purposes) are reproduced below. The highlighted aspects (bold/italicized) should provide valuable insight. I am confident a local library can obtain the text (if a medical-library is not available to you). c Blackwell Science Ltd 55 illustrations 488 pages Hardback 0632047658 Price œ65.00 March 1997 Related Titles New Developments in Cervical Cancer Screening and Prevention first editionEditors: E Franco, J Monsonego EUROGIN (European Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists who work on genital infections and their relationship to cancer. The aim is to promote and develop research, training, screening, prevention and information on genital infections, precancers and cancers in women. This book reviews the latest developments in the epidemiology, natural history and screening of cervical cancer. It also deals with management of cervical cancer, the development of vaccines against human papilloma virus - its major causative agent - and new technologies such as automated screening, HPV Testing and adjuvant tests to cytology.The final - and most important - part of the book lists the guidelines developed by the experts for cervical cancer the reason the meeting was held. Sixty papers presented at the EUROGIN meeting, covering the whole scientific and clinical experience of cervical cancer Contents Colombia and Spain and a Challenge for the FutureStatistical Issues in Studies of Human Papillomavirus Infection and Cervical Cancer The Epidemiological Basis for Evaluating Screening Policies Section 4: Cytology Screening Programmes: Organization, Monitoring and Use of Resources for Screening Programmes Cervical Screening by General Practitioners and Nurses and Information Feedback SystemsScreening Programmes: Results and Expectations Screening for Cervical Cancer: Experience of the Nordic Countries Screening that Failed to Work Implementation and Evaluation of Cervical Cancer Screening Programmes in the European Union Organization and results of Cervical Cancer Screening in Europe Over the Past 20 YearsSpontaneous Screening: Benefits and Limitations Is Cervical Cancer Cytological Screening Valuable in Developing Countries? Screening in Cervical Cancer Prevention in Porto Alegre, Brazil: The Experience of a Programme in a Developing Country Section 5: Automation in Cytology: Automation and Cervical Cytopathology: An Overview Automation in Cervicovaginal Cytology: System Requirements and Benefits Automated Screening using the AutoPap 300 Device Liquid-based Cytology: Comparison of ThinPrep 2000 with Conventionally Prepared Pap Smears The History of Neural Network Technology in Cytology A Comparison of Automated and Manual Screening: Theoretical Considerations Cooperation of the Image Analyser and the Cytologist Advantages and Limitations of Automated Screening Systems in Developing and Developed Countries Section 6: Human Papillomavirus Testing: Methods of DNA Hybridization and their Clinical Applicability to Human Papillomavirus DetectionHuman Papillomavirus Testing for Primary Cervical Cancer Screening Human Papillomavirus DNA Testing Using Liquid-based Cytology Human Papillomavirus Testing for Diagnostic Triage of Minor-grade Cytological Abnormalities: The European PerspectiveUse of Human Papillomavirus Tying for Quality Assurance of Cytological Diagnosis Estimates of the Cost Impact of Introducing Human Papillomavirus Testing into a Cervical Screening Programme Viral Load as a Surrogate for Persistence in Cervical Human Papillomavirus Infection Molecular Variant Analysis as a Tool in Natural History Studies of Human Papillomavirus Infection and Cervical Neoplasia Happy reading, Frank